Ivanovo, Ivanovo, Russian Federation
Ivanovo, Ivanovo, Russian Federation
Ivanovo, Ivanovo, Russian Federation
Ivanovo, Ivanovo, Russian Federation
Ivanovo, Ivanovo, Russian Federation
UDK 616.62-003.7 Образование мочевых камней
V obzore na osnove analiza sobstvennyh i literaturnyh dannyh predstavleny i obsuzhdayutsya metody issledovaniya struktury, kolichestvennogo himicheskogo i mineralogicheskogo analiza mochevyh kamney i svyazi fiziko-himicheskih harakteristik konkrementov s imeyuschimi mesto dlya konkretnogo pacienta faktorami riska mochekamennoy bolezni, metabolicheskimi i geneticheskimi narusheniyami. Pokazano, chto mochevye kamni imeyut slozhnuyu organizaciyu, mogut soderzhat' mnozhestvo himicheskih soedineniy, celyy ryad kotoryh obrazuet ustoychivye mineralogicheskie fazy opredelennoy struktury. Rassmotreny osnovnye tipy mochevyh kamney i otmecheno, chto metody analiticheskoy himii, elementnogo i rentgenospektral'nogo mikroanaliza mogut byt' ispol'zovany dlya issledovaniya stroeniya mochevyh kamney, odnako ne pozvolyayut poluchit' svedeniy ob ih mineralogicheskom sostave i mikrostrukture, chto vazhno dlya diagnostiki prichin zabolevaniya. Metody skaniruyuschey elektronnoy mikroskopii, a takzhe metody polyarizacionnoy mikroskopii, IK-Fur'e spektroskopii i rentgenofazovogo analiza imeyut neosporimye preimuschestva pri analize mochevyh konkrementov i pozvolyayut naglyadno pokazat' kakim obrazom svedeniya o teksture poverhnosti kamney i nalichii v nih opredelennyh mineralogicheskih faz pozvolyayut proyasnit' prichinu kamneobrazovaniya i naznachit' sootvetstvuyuschee lechenie.
mochekamennaya bolezn', vysokaya recidivnost', klassifikaciya i sostav mochevyh kamney, metody analiza mineralogicheskogo i himicheskogo sostava konkrementov
1. Türk C., Knoll T., PetrikA., Sarica K., Skolarikos A., Straub M., Seitz C. Guidelines on urolithiasis. EAU. 2019. 88 p.
2. Apolihin O.I., Sivkov A.V., Komarova V.A., Prosyannikov M.Yu., Golovanov S.A., Kazachenko A.V., Nikushina A.A., Shaderkina V.A. Zabolevaemost' mochekamennoy bolezn'yu v Rossiyskoy Federacii (2005-2016 gg.). Eksperimental'naya i klinicheskaya urologiya 2018. № 4. S. 4-14.
3. Chewcharat A., Curhan G. Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis. 2020. P. 1-13. DOI:https://doi.org/10.1007/s00240-020-01210-w.
4. Turney B.W., Reynard J.M., Noble J.G., Keoghane S.R. Trends in urological stone disease. BJU Int. 2012. V. 109. N 7. P.1082-1087. DOI:https://doi.org/10.1111/j.1464-410X.2011.10495.x.
5. Prosyannikov M.Yu., Anohin N.V., Golovanov S.A., Kirpatovskiy V.I., Sivkov A.V., Konstantinova O.V., Ivanov K.V., Apolohin O.I. Mochekamennaya bolezn' i serdechno-sosudistye zabolevaniya: tol'ko statisticheskaya svyaz' ili obschnost' patogeneticheskih mehanizmov? Eksperimental'naya i klinicheskaya urologiya. 2018. № 3. C. 35-41.
6. Yu Z., Yue W., Jiuzhi L., Youtao J., Guofei Z., Wenbin G. The risk of bladder cancer in patients with urinary calculi: a meta-analysis. Urolithiasis. 2018. V. 46. N 6. P. 573–579. DOI:https://doi.org/10.1007/s00240-017-1033-7
7. Straub M., Strohmaier W.L., Berg W., Beck B., Hoppe B., Laube N., Lahme S., Schmidt M., Hesse A., Koehrmann K.U. Diagnosis and metaphylaxis of stone disease. Consensus concept of the national working committee on stone disease for the upcoming German urolithiasis guideline. WJ Urol. 2005. V. 23. N 5. P. 309-323. DOI:https://doi.org/10.1007/s00345-005-0029-z.
8. Voschula V. I. Mochekamennaya bolezn': etiotropnoe i patogeneticheskoe lechenie, profilaktika. Minsk: VEVER. 2006. 268 s.
9. Strohmaier W.L., Seilnacht J., Schubert G. Clinical significance of uric acid dihydrate in urinary stones. Urol Res. 2011. V. 39. N 5. P. 357-360. DOI:https://doi.org/10.1007/s00240-010-0356-4.
10. Trinchieri A., Castelnuovo Ch., Lizzano R., Zanetti G. Calcium stone disease: a multiform reality. Urol. Res. 2005. V. 33. N 3. P. 194-198. DOI:https://doi.org/10.1007/s00240-004-0459-x
11. Daudon M., Bazin D., Jungers P., André G., Cousson A., Chevallier P., Veron E., Matzen G. Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques. J. Appl. Cryst. 2009. V. 42. N 1. P. 109-115. DOI:https://doi.org/10.1107/S0021889808041277 / fe5046Isup2.hkl
12. Kustov A.V., Strelnikov A.I. Quantitative mineralogical composition of calculi and urine abnormalities for calcium oxalate stone formers: a single-center results. Urol. J. 2018. V. 15. N 3. P. 87-91. DOI:https://doi.org/10.22037/uj.v0i0.3910
13. Schubert G. Stone analysis. Urol. Res. 2006. V. 34. P. 146 -150.
14. Ansari M.S., Gupta N.P., Hemal A.H., Dogra P.N., Seth A., Aron M., Singh T.P. Spectrum of stone composition: structural analysis of 1050 upper urinary tract calculi from northern India. Int. J. Urol.2005. V. 12. N 1. P. 12-16. DOI:https://doi.org/10.1111/j.1442-2042.2004.00990.x.
15. Schubert G. Urinary stone analysis / P.N. Rao, G.N. Preminger, J.P. Kavanagh (eds.). Urinary tract stone disease. L.: Springer-Verlag, 2011. P. 341-353.
16. Ryall R.L. The possible roles of inhibitors, promoters, and macromolecules in the formation of calcium kidney stones / P.N. Rao, G.N. Preminger, J.P. Kavanagh (eds.). Urinary tract stone disease. L.: Springer-Verlag, 2011. P. 31-60.
17. Stroup S.P. Urinary infection and struvite stones urinary tract stone disease / S.P. Stroup, B.K. Auge in Rao PN, Preminger GN, Kavanagh JP (eds.). Urinary tract stone disease. L.: Springer-Verlag, 2011. P. 217-224.
18. Carpentier X., Daudon M., Traxer O., Jungers P., Mazouyes A., Matzen G., Véron E., Bazin D. Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. Urology. 2009. V. 73. N 5. P. 968-975. DOI:https://doi.org/10.1016/j.urology.2008.12.049.
19. Kajander E.O., Ciftcioglu N., Aho K., Garcia Cuerpo. Characteristics of nanobacteria and their possible role in stone formation. Urol. Res. 2003. V. 31. P. 47-54. DOIhttps://doi.org/10.1007/s00240-003-0304-7.
20. Wood H.M., Shoskes D.A. The role of nanobacteria in urologic disease. World J. Urol. 2006. V. 24. P. 51-54. DOIhttps://doi.org/10.1007/s00345-005-0041-3.
21. Schubert G., Reck G., Jancke H., Kraus W., Patzelt Ch. Uric acid monohydrate – a new urinary calculus phase. Urol. Res. 2005. V. 33. P. 231-238. DOI:https://doi.org/10.1007/s00240-005-0467-5.
22. Strohmaier W.L., Seilnacht J., Schubert G. Clinical significance of uric acid dihydrate in urinary stones. Urol. Res. 2011. V. 39. P. 357-360. DOI:https://doi.org/10.1007/s00240-010-0356-4.
23. Grases F., Sanchis P., Perello J., Costa-Bauzá A. Role of uric acid in different types of calcium oxalate renal calculi. Int. J. Urol. 2006. V. 13. P. 252-256. DOI:https://doi.org/10.1111/j.1442-2042.2006.01262.x.
24. Sakhee Kh. Uric acid metabolism and uric acid stones / Kh. Sakhee in Rao PN, Preminger GN, Kavanagh JP (eds.). Urinary tract stone disease. L.: Springer-Verlag, 2011. P. 185-193.
25. Krombach P., Wendt-Nordahl G., Knoll T. Cystinuria and cystine stones / Rao PN, Preminger GN, Kavanagh JP (eds.). Urinary tract stone disease. L.: Springer-Verlag, 2011. P. 207-215.
26. Daudon M., Jungers P. Drug-induced renal stones / Rao PN, Preminger GN, Kavanagh JP (eds.). Urinary tract stone disease. L.: Springer-Verlag. 2011. P. 225-237.
27. Daudon M., Jungers P., Bazin D. Peculiar morphology of stones in primary hyperoxaluria. New Engl. J. Med. 2008. V. 359. N 1. P. 100-103. DOI:https://doi.org/10.1056/NEJMc0800990.
28. Kustov A.V., Berezin B.D., Trostin V.N. The complexon-renal stone interaction: solubility and electronic microscopy studies. J. Phys. Chem. B. 2009. V. 113. P. 9547-9550. DOI:https://doi.org/10.1021/jp901493x.
29. Kustov A.V., Berezin B.D., Strel`nikov A.I. Interaction of a complexing agent with urolith as the basis for efficient little-invasive therapy of phosphaturia. Dokl. Phys. Chem. 2009. V. 428. P. 175-177 (in Russian). DOI:https://doi.org/10.1134/S0012501609090048.
30. Kustov A.V., Strel'nikov A.I., Moryganov, Zhuravleva N.I., Ayrapetyan A.O. Kolichestvennyy mineralogicheskiy analiz i struktura mochevyh kamney pacientov Ivanovskoy oblasti. Urologiya. 2016. № 3. C. 19-25.
31. Bazin D., Leroy S., Tielens F. Bonhomme C., Bonhomme-Coury L., Damay F., Le Denmat D., Jérémy Sadoine, Rod J., Frochot V., Letavernie E., Haymann J-Ph., Daudon M. Hyperoxaluria is related to whewellite and hypercalciuria to weddellite: What happens when crystalline conversion occurs? Comptes Rendus Chimie. 2016. V. 19. N 11-12. P. 1492-1503. DOIhttps://doi.org/10.1016/j.crci.2015.12.011.
32. Antonova M.A. Primenenie kompleksa fiziko-himicheskih metodov dlya izucheniya mochevyh kamney i mochi i ustanovleniya svyazi mezhdu nimi: dis. ... kand. him. nauk. M.: MITHT. 2015. 154 s.
33. Bichler K.H., Lahme C., Mattauch W., Strohmaier W.L. Metabolische evaluation und metaphylaxe von harnsteinpatienten. Aktuel Urol. 2000. V. 31. P. 283-293. DOI:https://doi.org/10.1055/s-2000-7195.
34. Khan S.R., Kirk D.J. Modulators of crystallization of stone salts.Urinary stone disease: the practical guide to medical and surgical managemen / M.L. Stoller, M.V. Meng (eds.). NJ: Humana Press, 2007. P. 175-218.
35. Golovanov S.A., Sivkov A.V., Anohin N.V. Giperkal'ciuriya: principy differencial'noy diagnostiki. Eksperimental'naya i klinicheskaya urologiya. 2015. V. 4. P. 86-92.
36. Kustov A.V., Strelnikov A.I., Airapetyan A.O., Kheiderov Sh.M. New step-by-step algorithms for diagnosis of calcium oxalate urolithiasis based on a qualitative mineralogical composition of calculi. Clin. Neph. & Urol. Science. 2015. V. 2. P. 1-5. DOI:https://doi.org/10.7243/2054-7161-2-3.
